A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program

NCT07429942 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
94
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda